Literature DB >> 17138952

Depressive symptoms and risk of stroke: the Framingham Study.

Kimberly J Salaycik1, Margaret Kelly-Hayes, Alexa Beiser, Anh-Hoa Nguyen, Stephen M Brady, Carlos S Kase, Philip A Wolf.   

Abstract

BACKGROUND AND
PURPOSE: Emerging evidence raises the possibility of an association between depression and stroke risk. This study sought to examine whether depressive symptoms are associated with an increased risk of cerebrovascular events in a community-based sample.
METHODS: A prospective study was conducted on 4120 Framingham Heart Study participants aged 29 to 100 years with up to 8 years of follow-up. The Center for Epidemiologic Studies Depression Scale was used to measure depressive symptoms. Incident stroke and transient ischemic attack (TIA) events were assessed by uniform diagnostic criteria. The association between depressive symptoms and risk of stroke/TIA was analyzed with Cox proportional-hazards models, after adjusting for traditional stroke risk factors.
RESULTS: In participants <65 years, the risk of developing stroke/TIA was 4.21 times greater (P= <0.001) in those with symptoms of depression. After adjusting for components of the Framingham Stroke Risk Profile (hazard ratio=3.43, 95% CI=1.60 to 7.36, P=0.002) and education (hazard ratio=4.89, 95% CI=2.19 to 10.95), similar results were obtained. In subjects aged 65 and older, depressive symptoms were not associated with an increased risk of stroke/TIA. Taking antidepressant medications did not alter the risk associated with depressive symptoms.
CONCLUSIONS: In this community-based study, depressive symptoms were an independent risk factor for incident stroke/TIA in individuals <65 years. These data suggest that identification of depressive symptoms at younger ages may have an impact on the primary prevention of stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17138952     DOI: 10.1161/01.STR.0000251695.39877.ca

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  66 in total

Review 1.  Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.

Authors:  An Pan; Qi Sun; Olivia I Okereke; Kathryn M Rexrode; Frank B Hu
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

Review 2.  Epidemiology and prevention of stroke: a worldwide perspective.

Authors:  Elena V Kuklina; Xin Tong; Mary G George; Pooja Bansil
Journal:  Expert Rev Neurother       Date:  2012-02       Impact factor: 4.618

3.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 4.  Physical and mental health of homebound older adults: an overlooked population.

Authors:  Wei Qiao Qiu; Michael Dean; Timothy Liu; Linda George; Margery Gann; Joshua Cohen; Martha L Bruce
Journal:  J Am Geriatr Soc       Date:  2010-11-10       Impact factor: 5.562

5.  Association of quetiapine with ischemic brain stem stroke: a case report and discussion.

Authors:  Selma BozkurtZincir; Betul F Ozdilek; Serkan Zincir
Journal:  Ther Adv Psychopharmacol       Date:  2015-08

Review 6.  [Stroke prevention outside the pharmacy : risk factors and lifestyle].

Authors:  J Sobesky
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

Review 7.  Lipid effects of psychiatric medications.

Authors:  Junzo Watanabe; Yutaro Suzuki; Toshiyuki Someya
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

8.  Association of serotonin transporter gene polymorphisms with poststroke depression.

Authors:  Ruth Kohen; Kevin C Cain; Pamela H Mitchell; Kyra Becker; Ann Buzaitis; Steven P Millard; Grace P Navaja; Linda Teri; David Tirschwell; Richard Veith
Journal:  Arch Gen Psychiatry       Date:  2008-11

9.  Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study.

Authors:  Emily C O'Brien; Melissa A Greiner; Mario Sims; Natalie Chantelle Hardy; Wei Wang; Eyal Shahar; Adrian F Hernandez; Lesley H Curtis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-17

10.  Persistent cognitive depressive symptoms are associated with coronary artery calcification.

Authors:  Mark Hamer; Mika Kivimaki; Avijit Lahiri; Michael G Marmot; Andrew Steptoe
Journal:  Atherosclerosis       Date:  2010-02-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.